The proliferation of irrational metformin fixed-dose combinations in India-Reference-Cited by-同舟云学术

The proliferation of irrational metformin fixed-dose combinations in India

Published:2015-02 Issue:2 Volume:3 Page:98-100
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Evans Valerie,Pollock Allyson M

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference8 articles.

1. India should introduce a new Drugs Act;Roderick;Lancet,2014

2. List of drugs prohibited for manufacture and sale through gazette notifications under Section 26A of Drugs & Cosmetics Act 1940 by the Ministry of Health and Family Welfare,2012

3. Fixed dose combinations approved by DCGI since 1961 til February 2013,2013

4. Public health: India's diabetes time bomb;Shetty;Nature,2012

5. National list of essential medicines of India,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Negative Incentives and Regulatory Capture: Noncompliance with Price Ceilings on Essential Medicines in India;Journal of Management Studies;2022-12-02

2. Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel;Journal of Family Medicine and Primary Care;2020

3. From courts to markets: New evidence on enforcement of pharmaceutical bans in India;Social Science & Medicine;2019-09

4. Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India;BMJ Global Health;2018-03

5. Availability of brands of six essential medicines in 124 pharmacies in Maharashtra;Journal of Global Health;2018-01-24